Hemodynamic Effects of SGLT2 Inhibitors in Patients with and Without Diabetes Mellitus—A Narrative Review

Roxana Brata, Andrei Vasile Pascalau, Ovidiu Fratila, Ioana Paul, Mihaela Mirela Muresan, Andreea Camarasan, Tiberia Ilias · 2024

Read Hemodynamic Effects of SGLT2 Inhibitors in Patients with and Without Diabetes Mellitus—A Narrative Review by Roxana Brata, Andrei Vasile Pascalau, Ovidiu Fratila, Ioana Paul, Mihaela Mirela Muresan, Andreea Camarasan, Tiberia Ilias (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11641081.txt.

Description

Roxana Brata and co-authors review how diabetes drugs of the SGLT2 class reshape blood flow forces in heart and kidney, in work from twenty twenty-four. Two flagship drugs anchor the narrative review's evidence. Blocking sugar and sodium uptake in the kidney starts the cascade. Water follows the blocked sodium out of the body. Pressure inside the kidney's filters eases under treatment.

Heart filling pressures and vessel stiffness also improve measurably. One drug cuts kidney disease progression risk nearly in half. Blood pressure and body weight drift downward together. Hospital stays and deaths fall across the trial literature. Exact mechanisms remain partly mysterious despite the clear benefits. Guidelines now build heart and kidney care around these drugs.

Catalog record

CREATORRoxana Brata, Andrei Vasile Pascalau, Ovidiu Fratila, Ioana Paul, Mihaela Mirela Muresan, Andreea Camarasan, Tiberia Ilias
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE27 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11641081

Browse the full library · About the Tower of Babel